Related Experiment Video

Updated: Nov 7, 2025

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
05:05

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

Published on: November 29, 2018

11.1K

MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model

Mei Qi Kwa1, Rafael Brandao1, Trong H Phung1,2

  • 1Biotech Research and Innovation Center (BRIC), University of Copenhagen, Ole Maaløes vej 5, 2200 Copenhagen, Denmark.

Cells
|April 30, 2021
PubMed

Insights

Myotonic dystrophy-related cytoskeletal kinase alpha (MRCKα) is amplified in breast cancer. Loss of MRCKα in mice and cell lines showed limited impact on cancer development, suggesting it may be a prognostic marker with minor functional roles.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Myotonic dystrophy-related cytoskeletal kinase alpha (MRCKα) is a serine/threonine kinase involved in cell contraction and F-actin dynamics.
  • MRCKα is amplified in human breast cancer and associated with poor prognosis.
  • The in vivo function of MRCKα remains largely unknown.

Purpose of the Study:

  • To investigate the in vivo function of MRCKα in mouse development and breast cancer.
  • To explore the role of MRCKα in breast cancer cell invasion and migration.
  • To analyze the co-amplification of MRCKα with other oncogenes in human breast cancers.

Main Methods:

  • Generation of mice lacking a functional MRCKα gene.
  • Assessment of breast cancer development in MMTV-PyMT transgenic mice lacking MRCKα.
  • Deletion of MRCKα and MRCKβ in triple-negative breast cancer cell lines (MDA-MB-231 and 4T1).
  • Genomic analysis of human breast cancer samples.

Main Results:

  • Mice lacking MRCKα exhibited normal development and mammary gland formation.
  • Loss of MRCKα did not influence tumor onset, growth, or metastasis in the MMTV-PyMT model.
  • Deletion of MRCKα reduced invasion in MDA-MB-231 cells but not migration in 4T1 cells.
  • MRCKα is frequently co-amplified with oncogenes ARID4B and AKT3 in human breast cancers.

Conclusions:

  • MRCKα may serve as a prognostic marker for breast cancer.
  • The functional importance of MRCKα in breast cancer development and progression appears limited.
  • Co-amplification with ARID4B and AKT3 may contribute to MRCKα's prognostic value.
Keywords:
MRCKbreast cancerinvasion

More Related Videos

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

23.6K
Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland06:29

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Published on: June 7, 2019

13.1K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.0K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.6K
Mismatch Repair01:36

Mismatch Repair

Overview
42.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K